Stay updated on Pembrolizumab Combo for Melanoma Brain Metastasis Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab Combo for Melanoma Brain Metastasis Clinical Trial page.

Latest updates to the Pembrolizumab Combo for Melanoma Brain Metastasis Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedRevision updated from v3.4.1 to v3.4.2 in the page header/footer.SummaryDifference0.0%

- Check15 days agoChange DetectedAdded Revision: v3.4.1 to the history; removed the government funding lapse notice and the prior v3.4.0 reference.SummaryDifference0.4%

- Check22 days agoChange DetectedAdded a government funding lapse notice at the top of the page informing users that some information may not be up to date and transactions may not be processed. It also directs users to cc.nih.gov and opm.gov for current operating status.SummaryDifference0.3%

- Check29 days agoChange DetectedAdds a glossary display and color-coded highlights for additions (green) and deletions (red), and updates the revision label to v3.4.0. The No FEAR Act data wording is adjusted for capitalization.SummaryDifference0.5%

- Check36 days agoChange DetectedRevision history updated: added v3.3.4 and removed v3.3.3. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check65 days agoChange DetectedA minor site maintenance update adds Revision: v3.3.3 and removes older notes; this does not affect trial data or the public record. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab Combo for Melanoma Brain Metastasis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Combo for Melanoma Brain Metastasis Clinical Trial page.